Cost-Effectiveness

Trial Finds Some Early Breast Cancer Patients Can Skip Sentinel Node Biopsy Without Harming 5-Year Control

Investigators urge cautious adoption given per-protocol analysis, incomplete follow-up, reliance on whole-breast irradiation.